ESS and MAX IV research approved for EU funding
16 June 2015
The ESS and MAX IV: Cross Border Science and Society project application has been approved for EU funding. The research facilities will create a world leading hub for R&D in biomedicine, medicine, material technology, nanotechnology, energy research, geology and environmental science.
The EU has approved funding for the project "ESS and MAX IV: Cross Border Science and Society", aiming to create a cross-border network and research training programme linked to the research facilities ESS and MAX IV. The project involves universities, municipalities, government authorities and various organisations.
During the three-year project period, the ESS and MAX IV Cross Border Science and Society is, among other things, expected to:
- Built a research network with 150 persons from research and industry.
- Foster 176 cross-border trials / research projects.
- Employ 40 new researchers at ESS and MAX IV.
ESS and MAX IV: making possible new advances
The European Spallation Source (ESS) will be a world leader for material research and life sciences where neutrons are to be used to screen a wide range of materials from proteins and plastics to medicines and molecules at the atomic level. The ESS research centre will be based on the world's most powerful neutron source. Having 17 partner countries, the ESS will be hosted by Sweden and Denmark and built in Lund and Copenhagen. The first neutrons can be produced in 2018/2019 and the facility will be completely up and running in 2023.
The MAX IV Laboratory will be the most powerful synchrotron radiation facility in the world, located in Lund, Sweden. MAX IV will make possible new advances in a wide range of areas such as biomedicine, medicine, material technology, nanotechnology, energy research, geology and environmental science.
The ESS and MAX IV complement one another in their study of various materials and can thus create significant synergy effects.
Source: News Øresund (In Danish)